Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer

Oncology Reports

Volumn 15, Issue 2, 2006, Pages 437-442

  Takanami, Iwao ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

D2 40; Immunohistochemistry; Lymph node metastasis; Lymphangiogenesis; Non small cell lung cancer

Indexed keywords

ANGIOTENSIN DERIVATIVE; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D2 40; MONOCLONAL ANTIBODY D2-40; TUMOR MARKER; VASCULAR ENDOTHELIAL GROWTH FACTOR C, HUMAN; VASCULOTROPIN C;

ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; LYMPH VESSEL ENDOTHELIUM; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS;

ANGIOTENSINS; ANTIBODIES, MONOCLONAL; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIUM, LYMPHATIC; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 33744462916     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.2.437     Document Type: Article

References (24)

1. Marks A, Sutherland DR, Bailey D, et al: Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testinal germ cell tumors. Br J Cancer 80: 569-578, 1999. (Pubitemid 29213215)
2. Kahn HJ and Marks A: A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors. Lab Invest 82: 1255-1257, 2002. (Pubitemid 35014860)
3. Nisato RE, Tille JS and Pepper MS: Lymphangiogenesis and tumor metastasis. Thromb Haemost 90: 591-597, 2003. (Pubitemid 37287626)
4. Jeltsch M, Kaipainen A, Joukov V, et al: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425, 1997. (Pubitemid 27235412)
5. Maisonpierre PC, Suri C, Jones PF, et al: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is resqued by angiopoietin-1. Dev Cell 3: 411-423, 2002.
6. Takahashi M, Yoshimoto T and Kubo H: Molecular mechanisms of lymphangiogenesis. Int J Hematol 80: 29-34, 2004. (Pubitemid 38937872)
7. Takanami I, Takeuchi K and Naruke M: Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88: 2686-2692, 2000. (Pubitemid 30417928)
8. Hoar FJ, Chaudri S, Wadley MS and Stonelake PS: Co-expression of vascular endothelial growth factor C (VEGF-C) and c-erb B2 in human breast carcinoma. Eur J Cancer 39: 1698-1703, 2003. (Pubitemid 36897606)
9. Tanaka F, Ishikawa K, Yanagihara K, et al: Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 62: 7124-7129, 2002. (Pubitemid 35424109)
10. Ginsberg R, Vokes E and Raben A: Non-small cell lung cancer. In: Cancer: Principles and Practice of Oncology. DeVitaV Jr, Helleman S and Rosenberg S (eds). Lippencott-Raven, Philadelphia, pp858-911, 1997.
11. Naruke T, Goya T, Tsuchiya R and Suematsu K: Prognosis and survival in resected lung carcinoma based on the international staging system. J Thorac Cardiovasc Surg 96: 440-447, 1998.
12. Macchiarini P, Fontaini G, Hardlin MJ, Squantini F and Angellitti GA: Regulation of neovasculisation to metastasis of non-small cell lung cancer. Lancet 340: 145-146, 1992.
13. Padera TP, Kadambi A, DiThomaso E, et al: Lymphatic metastasis in the absent of functional intratumoral lymphatics. Science 296: 1883-1886, 2002. (Pubitemid 34596277)
14. Choi WWL, Lewis M, Lawson D, et al: Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression. Modern Pathol 18: 143-152, 2005. (Pubitemid 40128107)
15. Bono P, Wasenius VM, Heikkila P, Lundin J, Jackson DG and Joensuu H: High Lyve-1 positive lymphatic vessel numbers are associated with poor outcome in breast cancer. Clin Can Res 10: 7144-7149, 2004. (Pubitemid 39487698)
16. Cao Y, Linden P, Farnebo J, et al: Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Acad Sci USA 85: 14389-14394, 1998. (Pubitemid 28549377)
17. Sendivy R, Beck-Managetta J, Haverkampf C, Battistutti W and Henigschnabel S: Expression of vascular endothelial growth factor-C correlates with lymphatic microvessel density and the nodal status in oral squamous cell cancer. Oral Pathol Med 32: 4555-4560, 2003.
18. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y and Hirohashi S: Expression of vascular endothelial growth factor A, B, C, and D and theirrelationship to lymph node status in lung adenocarcinoma. Clin Cancer Res 6: 2431-2439, 2000. (Pubitemid 30399212)
19. Alitalo K and Carmeliet P: Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 1: 219-227, 2002. (Pubitemid 41039145)
20. Oki Y, Yasunaga K, Ito Y, et al: Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration. Proc Natl Acad Sci USA 100: 9494-9499, 2003. (Pubitemid 37033956)
21. Ochiumi T, Tanaka S, Oka S, et al: Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma. Int J Oncol 24: 539-547, 2004.
22. Sfiligoi C, deLuca AD, Cascone I, et al: Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103: 466-474, 2003. (Pubitemid 36020220)
23. Sun XD, Liu XE, Wu JM, Cai XJ, Mou YP and Li JD: Expression and significance of angiopoietin-2 in gastric cancer. World J Gastroenterol 10: 1382-1385, 2004.
24. Thurston G: Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis. Cell Tissue Res 314: 61-68, 2003.